(Sharecast News) - Celadon Pharmaceuticals reiterated on Wednesday that it has yet to receive funds under its secured credit facility, and was still facing significant funding uncertainty, raising the prospect of administration if additional financing is not secured promptly.
The AIM-traded company said there had been no material progress since its...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE